Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-20

Clinical Trial Update: Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating brain natriuretic peptide as a cardiac hormone replacement in heart failure and cardiomyopathy has completed and posted results. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Horng Chen | Conditions: Congestive Heart Failure, Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-12-20